Drug
14c Biib122
14c Biib122: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C] BIIB122 ([14C] DNL151) NCT05119790 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow 14c Biib122 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.